Annual CFO
-$818.80 K
-$814.60 K-19395.24%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual cash flow from operations is currently -$818.80 thousand, with the most recent change of -$814.60 thousand (-19395.24%) on 31 December 2023. During the last 3 years, it has fallen by -$818.30 thousand (-163660.00%). BLACU annual CFO is now -163660.00% below its all-time high of -$500.00, reached on 01 December 2021.BLACU Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$226.90 K
+$1.19 M+83.98%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly cash flow from operations is currently -$226.90 thousand, with the most recent change of +$1.19 million (+83.98%) on 30 September 2024. Over the past year, it has dropped by -$83.70 thousand (-58.45%). BLACU quarterly CFO is now -6071.05% below its all-time high of $3800.00, reached on 01 September 2022.BLACU Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$1.96 M
-$83.70 K-4.45%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit TTM cash flow from operations is currently -$1.96 million, with the most recent change of -$83.70 thousand (-4.45%) on 30 September 2024. Over the past year, it has dropped by -$1.42 million (-263.68%). BLACU TTM CFO is now -1964500.00% below its all-time high of -$100.00, reached on 01 March 2022.BLACU TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | -58.5% | -263.7% |
| 3 y3 years | -10000.0% | - | - |
| 5 y5 years | - | - | - |
BLACU Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -6071.1% | +84.0% | <-9999.0% | at low |
| 5 y | 5 years | <-9999.0% | at low | -6071.1% | +84.0% | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | -6071.1% | +84.0% | <-9999.0% | at low |
Bellevue Life Sciences Acquisit Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$226.90 K(-84.0%) | -$1.96 M(+4.4%) |
| June 2024 | - | -$1.42 M(+3288.5%) | -$1.88 M(+131.6%) |
| Mar 2024 | - | -$41.80 K(-85.0%) | -$812.10 K(-0.8%) |
| Dec 2023 | -$818.80 K | -$279.50 K(+95.2%) | -$818.70 K(+51.6%) |
| Sept 2023 | - | -$143.20 K(-58.8%) | -$540.20 K(+37.4%) |
| June 2023 | - | -$347.60 K(+618.2%) | -$393.20 K(+649.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$48.40 K(+4740.0%) | -$52.50 K(+1150.0%) |
| Dec 2022 | -$4200.00(+740.0%) | - | - |
| Dec 2022 | - | -$1000.00(-126.3%) | -$4200.00(+31.3%) |
| Sept 2022 | - | $3800.00(-155.1%) | -$3200.00(-54.3%) |
| June 2022 | - | -$6900.00(+6800.0%) | -$7000.00(+6900.0%) |
| Mar 2022 | - | -$100.00 | -$100.00 |
| Dec 2021 | -$500.00 | - | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual cash flow from operations?
- What is the all time high annual CFO for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual CFO year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly CFO year-on-year change?
- What is Bellevue Life Sciences Acquisit TTM cash flow from operations?
- What is the all time high TTM CFO for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit TTM CFO year-on-year change?
What is Bellevue Life Sciences Acquisit annual cash flow from operations?
The current annual CFO of BLACU is -$818.80 K
What is the all time high annual CFO for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual cash flow from operations is -$500.00
What is Bellevue Life Sciences Acquisit annual CFO year-on-year change?
Over the past year, BLACU annual cash flow from operations has changed by -$814.60 K (-19395.24%)
What is Bellevue Life Sciences Acquisit quarterly cash flow from operations?
The current quarterly CFO of BLACU is -$226.90 K
What is the all time high quarterly CFO for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly cash flow from operations is $3800.00
What is Bellevue Life Sciences Acquisit quarterly CFO year-on-year change?
Over the past year, BLACU quarterly cash flow from operations has changed by -$83.70 K (-58.45%)
What is Bellevue Life Sciences Acquisit TTM cash flow from operations?
The current TTM CFO of BLACU is -$1.96 M
What is the all time high TTM CFO for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high TTM cash flow from operations is -$100.00
What is Bellevue Life Sciences Acquisit TTM CFO year-on-year change?
Over the past year, BLACU TTM cash flow from operations has changed by -$1.42 M (-263.68%)